MOLECULIN BIOTECH INC (MBRX) Stock Analyst Earnings Estimates
NASDAQ:MBRX - Nasdaq - US60855D3098 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 127.27% | N/A 37.20% | N/A 17.74% | ||||||||||||
| EBITDA YoY % growth | -1.638M | -454K 72.29% | -3.877M -753.96% | -8.635M -122.72% | -14.957M -73.21% | -17.325M -15.83% | -19.542M -12.80% | -22.804M -16.69% | -30.51M -33.79% | -29.504M 3.30% | -26.515M 10.13% | N/A -26.56% | N/A | N/A | N/A 68.52% | N/A 465.69% | N/A 111.80% | N/A 83.16% | N/A | |
| EBIT YoY % growth | -1.649M | -465.3K 71.79% | -3.883M -734.56% | -8.653M -122.83% | -15.025M -73.64% | -17.524M -16.63% | -19.742M -12.66% | -22.968M -16.34% | -30.64M -33.40% | -29.631M 3.29% | -26.641M 10.09% | N/A -4.02% | N/A -3.12% | N/A 4.48% | N/A -11.35% | N/A 206.65% | N/A 251.76% | N/A 32.65% | N/A 21.99% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A -46.87% | -41.40 4.05% | -30.60 26.09% | -26.40 13.73% | -8.85 66.48% | -15.15 -71.19% | -15.07 0.53% | -6.94 53.93% | N/A 76.54% | N/A 25.47% | N/A -15.55% | N/A -206.91% | N/A 193.60% | N/A 167.34% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.37 78.20% | -0.28 90.10% | -0.38 -2.09% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -7.242M -18.29% | -8.466M -20.26% | -11.934M -83.12% |
| EBIT Q2Q % growth | -6.185M 0.00% | -6.36M 10.87% | -6.691M -0.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.69 65.84% | -0.57 | -0.12 | -21.89% |
| Q4 2024 Q2Q % growth | -0.37 92.57% | -1.31 | 0.94 | 71.50% |
| Q3 2024 Q2Q % growth | -2.85 | -2.49 | -0.36 | -14.51% |
| Q2 2024 Q2Q % growth | -1.70 43.33% | -2.56 | 0.86 | 33.60% |
| Q1 2024 Q2Q % growth | -2.02 51.90% | -3.60 | 1.58 | 43.90% |
| Q4 2023 Q2Q % growth | -5.02 -45.51% | -3.11 | -1.91 | -61.37% |
| Q3 2023 Q2Q % growth | -2.85 36.67% | -3.62 | 0.77 | 21.29% |
| Q2 2023 Q2Q % growth | -3.00 16.67% | -4.18 | 1.18 | 28.26% |
| Q1 2023 Q2Q % growth | -4.20 -16.67% | -3.83 | -0.38 | -9.80% |
| Q4 2022 Q2Q % growth | -3.45 -155.56% | -4.64 | 1.19 | 25.66% |
| Q3 2022 Q2Q % growth | -4.50 -100.00% | -4.13 | -0.37 | -8.93% |
| Q2 2022 Q2Q % growth | -3.60 -60.00% | -3.85 | 0.25 | 6.44% |
| Q1 2022 Q2Q % growth | -3.60 -20.00% | -3.24 | -0.36 | -11.25% |
| Q4 2021 Q2Q % growth | -1.35 65.38% | -3.21 | 1.86 | 57.98% |
| Q3 2021 Q2Q % growth | -2.25 58.33% | -3.06 | 0.81 | 26.47% |
| Q2 2021 Q2Q % growth | -2.25 85.29% | -2.86 | 0.61 | 21.22% |
| Q1 2021 Q2Q % growth | -3.00 -66.67% | -3.51 | 0.51 | 14.63% |
| Q4 2020 Q2Q % growth | -3.90 45.83% | -8.82 | 4.92 | 55.80% |
| Q3 2020 Q2Q % growth | -5.40 33.33% | -8.57 | 3.17 | 36.97% |
| Q2 2020 Q2Q % growth | -15.30 -466.67% | -8.26 | -7.04 | -85.19% |
| Q1 2020 Q2Q % growth | -1.80 85.71% | -9.18 | 7.38 | 80.39% |
| Q4 2019 Q2Q % growth | -7.20 | -10.10 | 2.90 | 28.70% |
| Q3 2019 Q2Q % growth | -8.10 | -7.80 | -0.30 | -3.81% |
| Q2 2019 Q2Q % growth | -2.70 | -9.64 | 6.94 | 71.99% |
| Q1 2019 Q2Q % growth | -12.60 | -8.26 | -4.34 | -52.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.39% | 5.63% | 4.77% | 4.77% |
| Revenue | N/A | N/A | N/A | N/A |